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Prostacyclin is generated by cultured rat endothelial cells. Compound blocking activity of protein kinase C and cyclic nucleotide-dependent protein 
kinases (H7) and compound blocking interaction between Ca2 + and calmodulin (W7) diminish generation of prostacyclin in rat endothelial cells. 
These compounds give a synergistic effect when they are introduced to the endothelial cell cultures imultaneously. Compound HA1004, an inhibitor 
of CAMP- and cGMP-dependent protein kinases has no effect on prostacyclin generation. Lipoxin A4, a potent direct stimulator of protein kinase 
C, rapidly induces prostacyclin generation in rat endothelium in a dose- and time-dependent fashion. Lipoxin All-induced generation of prostacyclin 
can be inhibited by H7 and W7 but not by HA1004 Lipoxin B4 has no significant effect on prostacyclin generation in rat endothelium. In 
conclusion, our results demonstrate that generation of prostacyclin by rat endothelial cells is regulated via a pathway involving protein kinase 
C and Caz+. 
Endothelium; Prostacyclin generation; Lipoxin; Protein kinase C 
1. INTRODUCTION Twenty-four hours after seeding, the cells were used for the ex- 
periments. 
One of the important functions of endothelial cells 
(EC) is production of prostacyclin (PGIz), a potent 
vasodilator and an agent preventing platelet aggrega- 
tion. Generation of PGIz is regulated by several protein 
and lipid mediators [l-3]. In some cells, protein kinase 
C (PKC) has been shown to participate in the transduc- 
tion of the signal leading to the generation of PGIz 
[4-61. 
2.2. Chemicals 
Lipoxin A.+ (LXA.+) and lipoxin B4 (LXB4) were obtained from 
Cayman Chemicals (Ann Arbor, MI, USA). Protein kinase inhibitors 
H7, W7 and HA1004 were obtained from Seikagaku America (St. 
Petersburg, FL, USA). Radioimmunoassay (RIA) kits for the 
measurement of 6-keto-prostaglandin Fl alpha (6-keto-PGFla) were 
from Amersham (England). 
2.3. Prostacyclin measurements 
We examined the generation of PGIz by non- 
stimulated or lipoxin (LX)-treated rat heart EC. To ex- 
amine the role of protein kinases in the generation of 
PGI2, we employed 3 inhibitors of protein kinase ac- 
tivities: H7, a blocker of PKC and CAMP- and cGMP- 
dependent protein kinase (CAMP-PK and cGMP-PK, 
respectively) activities [7], W7, a blocker of the interac- 
tion between calmodulin and Ca2+ [8], and HA1004, a 
blocker of the CAMP-PK and cGMP-PK activities [9]. 
EC were induced to generate PGI2 by changing the culture medium 
in the microwells to fresh medium. In the experiments where the ef- 
fects of different chemicals on the generation of PGIz were examin- 
ed, new medium was supplemented with LX and/or with inhibitors 
of protein kinase activities. Levels of PGI2 were assessed by radioim- 
munoassay of 6-keto-PGFla after different periods of incubation at 
37°C. Results presented in the figures are pg 6-keto-PGFla/lOOpl 
sample of culture medium obtained from microwells containing 104 
EC in 250~1 of culture medium. Results are mean values of 3-5 
determinations. Statistical significances were counted using the Stu- 
dent’s I-test. 
2.4. PKC acdvity measurements 
2. MATERIALS AND METHODS 
2.1. Isolation and culture of rat heart endothelial cells 
EC were isolated from 7-lo-day-old DA rat hearts according to 
the modified method of Kasten [lo], as described in detail elsewhere 
[11,12]. Endothelial origin of the cells had been confirmed on the 
basis of their growth pattern and antigen expression [l l-131. EC 
were seeded at the density of 104 cells/microwell (96 wells/plate) in 
250 ,uI of culture medium (D-Val MEM + 10% FCS + gentamycin). 
Activity of PKC, in the presence of compounds H7, W7 and 
HA1004, was measured in crude extracts obtained from EC cultures. 
The enzyme activity measurement and procedure of obtaining the 
crude extract containing PKC was described in detail by Kikkawa et 
al. [14]. 
3. RESULTS 
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EC constitutively generate PGIz. Removal of PGI2 
from the culture medium of EC, by changing the 
culture medium, stimulates generation of this com- 
pound (measured as the level of 6-keto-PGFla) until 
the basal level of the culture medium is reestablished. 
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Pig. 1. Generation of PC&, by rat heart EC, induced by change of 
the culture medium to fresh medium (nil) or to fresh medium 
supplemented with different amounts (5, 10 or 15pM) of LX& 
Vahaes are means of 5 separate xper~meuts. Statisticai signifieances 
in Student’s I-test: * P < 0.1; ** P CC 0.01; *** P c 0.001. 
For non-stimulated rat heart EC, seeded at a density of 
lti cells/microwell in a volume of 250~1 of culture 
medium, the basal level of PGIs is 180-250 pg/lOOpl 
of the culture medium and is generated within 30 min. 
However, the highest rate of PC& generation occurs 
within the first 10 min (Fig. 1, nil treatment curve). 
It was possible to modulate the generation of PGIz 
by rat heart EC in culture, which is induced by a change 
of the culture medium, with inhibitors of the activities 
of several protein kinases, H7 inhibits the activities of 
3 protein kinases: PKC <i = 6.0 PM), CAMf-FE; (lu = 
3.0 pM), and cGMP-PK (& = 5.8 FM). At a concentra- 
tion of 10 mM, it had a very weak effect on the genera- 
tion of PGI2, but at a concentration of 30 mM, it 
diminished the level of PGIz in the culture medium 
(Fig. 2A). HA1004, at low concentrations, is an in- 
hibitor of CAMP-PK and cGMP-PK (Ki = 2.3 and 
1.3 pM, respectively), whereas higher concentrations 
affect also the activity of PKC (Xi = 40.0 FM). In our 
experiments, the presence of a 2 mM concentration of 
HA1004 in the culture medium led to increased genera- 
tion of PGIa exceeding the basal level. HAlOO4, at a 
concentration of 10 mM still had a potentiating effect 
on the generation of PGIz, but the effect was lower 
than with the 2 mM concentration of this inhibitor 
(Fig. 2B). W7 is a compound known to block 
calmodulin-Ca2+ interactions (ICso = 31 pM). It had a 
strong inhibitory effect on the generation of PGI2 at 
concentrations ranging from 20 to JO mM (Fig. 2C). 
However, at a concentration of 20 mM, W7 had only 
a short-lasting inhibitory effect (Fig. 2C). Treatment of 
EC with a combination of H7 and W7, at low comen- 
trations of fO and 20 m&l, respectively, produced a 
synergistic in~bitory effect (Fig* 2D). 
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Pig. 2. Effects of protein kinase inhibitors: H7 (A), HA1004 (B), W7 
(C) and H7 + W7 (II) on the generation of PGlz by rat EC after 
change of culture medium. Values are means f SD of 3 separate 
experiments. Statistieai significances in Student’s t-test: * P < 0.1; 
Because the above results suggested involvement of 
the PKC pathway in the generation of PGI2, ex- 
periments were done to examine the effect of H7, W7 
and HA1004 on the PKC activity, As seen in Table I, 
all tested compounds had an inhibitory effect on PKC 
activity, However, inhibition of PKC activity varied 
between inhibitors and was dependent on the inhibitor 
Table I 
The effect of compounds H7. WI and HA1004 on the activity of 
protein kinase C 
Compound 
H7 
W7 
HAltIO4 
Concentration Inhibition of 
&M) PKC activity (%) 
10 48 f 5 
30 95 f 5 
20 10 * 7 
50 69 It 8 
2 4*3 
ID 14 * 5 
Inhibition vahtes are means + SD of 3 separate xperiments 
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Fig. 3. Effect of the inhibitors of protein kinase activity, H7, W7 and 
HA1004 added to the cultures of rat EC 10 min prior to addition of 
LX&. The concentration of 6-keto-PGFla was measured 10 min (A) 
and 30 min (B) after introduction of LXA.I to the cultures of EC. 
Values are means f SD of 3 separate experiments. Statistical 
significances in Student’s t-test: * P < 0.1; ** P < 0.01; *** P < 
0.001. 
concentration used. These results are in agreement with 
results published by others [15,16]. 
LX have been demonstrated to induce generation of 
PGIz by cultured human umbilical cord EC [2]. 
Moreover, it has been suggested that, similarly to other 
arachidonic acid cascade compounds, LX activate PKC 
directly [17]. Therefore, we examined the effect of 
LxA4 and LXB4 on the generation of PGIz by rat EC 
as well as the effect of protein kinase inhibitors on the 
LX-induced generation of PGIz. LX used in ex- 
periments demonstrated ifferent potentials to induce 
PGL. LX& had a strong dose- and time-dependent 
enhancing effect (Fig. l), whereas LXB4 failed to in- 
crease significantly the generation of PGI2 (not shown). 
When both LXs were combined for treatment of EC, 
no synergistic or antagonistic effect of LXB4 was 
observed on the LX&-induced generation of PGI2 (not 
shown). 
Inhibitors of protein kinase activities, such as H7, 
W7 or HA1004, when added to the EC cultures 
simultaneously with LxA4, did not have significant ef- 
fects on the generation of PGI2 (not shown). However, 
when they were added to the EC cultures 10 min prior 
to adding LxA4, some of them had a significant effect 
on LXA4-induced generation of PGI2. H7 and W7 in- 
hibited LX&-induced generation of PGI2 but their ef- 
fect was short lasting, and the level of PGIz equal to 
this generated by LXA_I alone, was reached by EC 
within 30 min. HA1004, at a concentration of 10 mM, 
had an inhibitory effect on LXA4-induced generation 
of PGIz, and similarly to H7 and W7. The level of PGIz 
equal to this, induced by LX& alone, was established 
within 60 min after introduction of inhibitor to the cell 
cultures. When H7 and W7, at concentrations of 
30 mM and 50 mM, respectively, were added together 
to the EC cultures, a strong synergistic inhibitory effect 
on the generation of PGIz was obtained (Fig. 3). 
4. DISCUSSION 
Generation of PGIz is one of the major functions of 
EC [l&20] and in human EC this process has been 
shown to be regulated by PKC [4]. Our results suggest 
that also in rat heart EC PGIz generation is regulated 
via a pathway involving PKC. Generation of PGIz was 
inhibited by compound H7 blocking activity of PKC, 
CAMP-PK, cGMP-PK, and compound W7, whereas 
compound HA1004, at a concentration inhibiting the 
activities of CAMP-PK and cGMP-PK only, did not in- 
hibit PGIz generation but even increased it. It suggests 
that PKC and Ca2+ are involved in the generation of 
PGIz by rat EC. This finding is also supported by the 
observed inhibitory effects of all compounds on the 
PKC activity itself. The observation that HA1004 in- 
creases PGIz production by EC correlates with the fin- 
ding by Kroll et al. [21] who demonstrated that cyclic 
AMP, a stimulator of CAMP-PK, inhibits the produc- 
tion of PGI2. This may suggest hat PGG production 
by rat EC might be positively regulated by PKC and 
negatively regulated by CAMP-PK. Therefore, since 
PGI2, similarly to other prostaglandins, exerts its ac- 
tions on the cells by increasing the cytosolic levels of 
CAMP, it suggests the existence of a negative feed-back 
self-regulatory system in the generation of PGIz by EC. 
Brezinski et al. [2] have demonstrated that LX& is 
able to increase the production of PGIz by human EC. 
LxA4, as well as LXB4, have been demonstrated to in- 
duce direct activation of PKC [17]. Our results are in 
agreement with these findings. First, LX&, but not 
LXB4, induces the generation of PGIz by rat EC in a 
time- and dose-dependent manner. It was possible to 
diminish the effect of LxA4 on the generation of PG12 
with H7 and W7 but not with HA1004. However, the 
inhibitors exerted their effect on PGIz generation only 
when they were added to the EC cultures at least 10 min 
prior to addition of L%. This may suggest hat the 
penetration rate of these inhibitors is slower than that 
of LX& [15]. Another observation of ours, that the ef- 
fects of H7 and W7 on the non-treated EC lasts longer 
than effects of these inhibitors on EC treated with 
LX&, suggests that either La-activated PKC do not 
respond significantly to the inhibitors used, or that the 
presence of LX& hastens the process of recovery of 
the ability of the PKC to bind ATP [15]. Longer prein- 
cubation periods, up to 60 min, did not cause signifi- 
cant effects as compared to 10 min preincubation times 
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(not shown). Synergism of inhibitory effects of H7 and 
W7 on the generation of PGIz by EC stimulated with 
LX& supports the suggestion that protein kinase C is 
involved in the LX&-dependent PGIz generation 
(similarly to native generation of PGI2) [16]. 
The biological significance of the finding that LX& 
increases the generation of PC& by EC is still 
unknown. As a main source of LX, eosinophils have 
been named. Therefore, it is possible to speculate that 
in pathological conditions in sites where eosinophilia 
occurs (e.g. the often-observed blood eosinophilia 
preceding transplant rejection, [22]), the locally pro- 
duced LX might serve as triggers of the self-protecting 
mechanism leading to the protection of the EC from 
the damage via increased generation of PGI2. 
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